Contraception and Pregnancy Prevention for Transgender And

Contraception and Pregnancy Prevention for Transgender And

<p>Contraception and pregnancy prevention for transgender and gender nonbinary individuals across the gender spectrum </p><p>Chance Krempasky, FNP, WHNP (he/him) Callen-Lorde Community Health Center <br>New York, NY USA </p><p><strong>Intros/Who's in the room? </strong></p><p><strong>A Little About Callen-Lorde... </strong><br><strong>Introduction </strong></p><p>• Transmasculine persons (TMGNB=transgender men and gender nonbinary persons who are assigned female at birth), may utilize testosterone as part of gender affirmingtherapy </p><p>• They may have a uterus + ovaries and be capable of achieving pregnancy <br>• They also may engage in sexual activity which can achieve pregnancy </p><p><strong>TMGNB people can still get pregnant, even if they are on testosterone and </strong></p><p><strong>haven’t had a recent period. </strong></p><p><strong>Pregnancy in TMGNB persons </strong></p><p>• 31% trans masculine persons, 67% trans femininepersons believed or were unsure if gender affirminghormone therapy (GAHT) prevents pregnancy </p><p>• 6% trans feminine, 9% trans masculine reported that a provider stated that GAHT prevents pregnancy </p><p>• 3% TMGNB/trans masculine had </p><p>unplanned pregnancies </p><p><strong>Contraception Knowledge in TMGNB </strong></p><p><strong>Persons </strong></p><p>• Many believed testosteronefunctioned as a contraceptive </p><p>• Respondents reported receiving unclear or confusing informationfrom clinicians on need for </p><p>contraception while on GAHT </p><p>• Concerned contraception would interfere with </p><p>masculinizing effectsof GAHT </p><p><strong>Pregnancy in TMGNB Persons </strong></p><p>• 16.4% of TMGNB persons believed that GAHT is a contraceptive • 5.5% reported a provider stated that GAHT prevents pregnancy • 17% had been or were currently pregnant (11/60 pregnancies with current or past GAHT use) </p><p>• 60 pregnancies reported, 10 (17%) pregnancies occurred after stopping testosterone, 1 (1.6%) while taking testosterone irregularly </p><p><strong>Clinical Barriers to TransmasculineContraception </strong></p><p>• Unger, AJOG 2015: <br>• Less than one third of OBGYN clinicians surveyed recently stated that they were comfortable providing care forTM individuals </p><p>• NCTE U.S. Transgender Survey, 2015: <br>• One third of transgender respondents who had engaged in healthcare reporting at least one negative experience related to their gender identity, including verbal harassment and being </p><p>refused care </p><p>• Krempasky, AJOG 2019 <br>• TM patients may want to avoid estrogen and/or progesterone due to perceived feminizing effectsof these hormones and association with an incongruent gender </p><p>Will Betke-Brunswick, </p><p>"A Trans Man’s Experience With Birth </p><p>Control" </p><p><strong>and estrogen! </strong></p><p>• Pregnancy can occur even while amenorrheic from testosterone </p><p><strong>Effects of GAHT on Fertility </strong></p><p>• GAHT's long term effects on fertility are unclear </p><p>• True decrease in fecundityafter discontinuance </p><p>of testosterone has yet to be ascertained <br>• All patients considering starting GAHT should be counseled about options for fertilitypreservation<sup style="top: -0.5em;">1 </sup></p><p>• Use of GAHT does not guarantee infertility <br>• The time to return of fertilityis unknown, route </p><p>dependent (topical vs short/long-acting </p><p>injectable testosterone), though some may experience permanent loss of fertility,or require assisted reproductive technologies </p><p>1. WPATH SOC7 </p><p><strong>Effects of Gender Affirming Hormone Therapy on Fertility </strong></p><p>• It is unknown how long of a testosterone washout period is appropriate prior to pregnancy </p><p>• Testosterone is a teratogen and is contraindicated during pregnancy </p><p>• GAHT is not a substitute for contraception in patients wishing to prevent pregnancy </p><p><strong>Why Isn't Testosteronea Contraception? </strong></p><p>Changes in both LH and FSH occur in hyperandrogenic systems (both in amplitudeand pulsatility), <br>Androgen Receptors </p><p>however they are not suppressed to prepubertal levels<sup style="top: -0.4375em;">1-3 </sup></p><p>1. Haraldsen et al, <em>Horm Behav</em>. 2007 </p><p>2. Spinder et al <em>J Clin Endocrinol Metab</em>. 1989 </p><p>3. Van Caenegem et al <em>Curr Opin Endocrinol Diabetes Obes</em>. 2015 </p><p><strong>Language and Gender </strong></p><p>Language about fertilityis very gendered </p><p>“women’s health,” “well woman visits,” “GYN,” etc </p><p>**Use gender-neutral terms whenever possible </p><p><strong>Naming Anatomy </strong></p><p>Patients may use different words to describe their body </p><p>parts from “anatomical” terms </p><p>Mirror language that people use for their own body parts </p><p><strong>Alternatives to Current Gendered Terminology </strong></p><p>Krempasky, et al. 2019 </p><p><strong>Suggested Sexual History Script </strong></p><p>Krempasky, et al. 2019 </p><p><strong>Anatomic Inventory </strong></p><p><strong>Organs Present&nbsp;Surgical Hx </strong></p><p>❑ Breasts ❑ Cervix </p><p>❑ Ovaries ❑ Penis ❑ Prostate </p><p>❑ Testes ❑ Uterus ❑ Vagina <br>❑ Bilateral breast augmentation ❑ Bilateral orchiectomy </p><p>❑ Vaginoplasty (penile inversion, colon graft) ❑ Bilateral total reduction mammoplasty ❑ Vaginectomy </p><p>❑ Metoidioplasty ❑ Phalloplasty ❑ Scrotoplasty ❑ Urethroplasty </p><p><strong>Who Needs Contraception? </strong></p><p>Krempasky, et al. 2019 </p><p><strong>Case Study #1 </strong></p><p>Danny, a 27yo G0P0 trans man comes in to ask questions about his pregnancy risk. He has been on testosterone for 1 year. He is monogamous with a trans female partner who is on estradiol injections and spironolactone, and who has had no bottom surgeries. He has condomless receptive frontal and anal sex with her. He wants </p><p>to know if it’s possible for him to get pregnant. </p><p>PMH: Anxiety, PSH: None, Meds: escitalopram 10mg po daily, testosterone cypionate 80mg subcutaneously weekly </p><p><strong>Case Study #1 </strong></p><p>How would you counsel this patient? </p><p>Will Betke-Brunswick, </p><p>"A Trans Man’s </p><p>Experience With Birth Control" <br>Will Betke-Brunswick, </p><p>"A Trans Man’s Experience With Birth Control" </p><p><strong>Contraception for Transgender Men </strong></p><p>1. No&nbsp;methods are contraindicated specifically due to TMGNB identity or hormone use </p><p>2. Comparative&nbsp;efficacyis the same as in use by cisgender&nbsp;women (LARCs &gt; others) </p><p>3. Various&nbsp;aspects (insertion, side effects) of </p><p>contraceptive methods may uniquely affect </p><p>TMGNB patients </p><p>Contraception for Transgender Men </p><p>Krempasky, et al. 2019 </p>

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    45 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us